Incannex Healthcare Inc. (IXHL)
2025-03-31 | 2024-12-31 | 2024-09-30 | ||
|---|---|---|---|---|
| Revenue from customers | - | 12 | 74 | |
| Research and development | 2,735 | 1,414 | 2,896 | |
| General and administrative | 2,268 | 3,602 | 3,432 | |
| Total operating expenses | 5,003 | 5,016 | 6,328 | |
| Loss from operations | -5,003 | -5,004 | -6,254 | |
| Eloc commitment fee | - | -1,095 | - | |
| Change in fair value of convertible rights | - | -179 | - | |
| Warrant issuance costs | 129 | - | - | |
| Interest income | 4 | 28 | 28 | |
| Interest expense | 132 | 171 | - | |
| Loss on extinguishment | -994 | - | - | |
| Foreign exchange gains/(losses) | 41 | -326 | -5 | |
| Gain on change in fair value of warrant liabilities | -1,824 | 103 | - | |
| R&d tax incentive | 421 | 956 | 811 | |
| Total other income, net | 1,035 | -890 | 834 | |
| Loss before income tax expense | -3,968 | -5,894 | -5,420 | |
| Net loss | -3,968 | -5,894 | -5,420 | |
| Currency translation adjustment, net of tax | -88 | -414 | 339 | |
| Total comprehensive loss | -4,056 | -6,308 | -5,081 | |
| Basic eps | -0.2 | -0.33 | -0.29 | |
| Diluted eps | -0.2 | -0.33 | -0.29 | |
| Basic average shares | 19,632,539 | 17,624,422 | 17,642,832 | |
| Diluted average shares | 19,632,539 | 17,624,422 | 17,642,832 | |